|
KafocinDrug - Kafocin The trade name of the product as shown on the labeling.
Dosage -
CAPSULE; ORAL
Active Ingredient(s) -
Cephaloglycin
Strength -
250MG
Applicant -
LILLY
New Drug Application (NDA) Number -
050219
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Eli Lilly And Co
Kafocin
Keflet Eq 250mg Base Tablet; Oral
Keflet Eq 250mg Base Tablet; Oral Keflet Eq 500mg Base Tablet; Oral Keflet Eq 500mg Base Tablet; Oral Keftab Eq 250mg Base Tablet; Oral Keftab Eq 333mg Base Tablet; Oral Keftab Eq 500mg Base Tablet; Oral Kafocin 250mg Capsule; Oral Cephalexin Eq 500mg Base Tablet; Oral Keflet Eq 1gm Base Tablet; Oral NewDrugInformation |